Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02296346 · ClinicalTrials.gov registry record · NA
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02296346 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 13 participants.
The verdict
NCT02296346, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
In this research study, the investigators will determine whether a procedure called Extracorporeal Photopheresis (ECP) is helpful in preventing progression of disability in people with SPMS when compared to monthly corticosteroid infusions. This study will determine whether ECP has an effect on inflammatory cells in people with SPMS and whether it has a beneficial therapeutic effect.
Interventions
- DRUG SoluMedrol
- DEVICE Extracorporeal Photopheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02296346
The ClinicalTrials.gov registry entry for NCT02296346 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SoluMedrol is the first listed.
NCT02296346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02296346 about?
NCT02296346 is a clinical study titled "Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis". In this research study, the investigators will determine whether a procedure called Extracorporeal Photopheresis (ECP) is helpful in preventing progression of disability in people with SPMS when compared to monthly corticosteroid infusions. This study will determine whether ECP has an effect on infl...
What is the current status of trial NCT02296346?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2014-10. Estimated completion is 2018-05-10.
What interventions are being tested in trial NCT02296346?
The interventions under investigation include: SoluMedrol (DRUG), Extracorporeal Photopheresis (DEVICE).
Who is sponsoring clinical trial NCT02296346?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.